Disciplined Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Disciplined Investments’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18	Closed	-$1.85K	–	1689
2023 Q2	$1.85K	Hold	18	–	–	﹤0.01%	690
2023 Q1	$1.97K	Hold	18	–	–	﹤0.01%	667
2022 Q4	$2.05K	Buy	18 +17	+1,700%	+$1.41K	﹤0.01%	609
2022 Q3	$0	Sell	1 -9	-90%	-$629	﹤0.01%	1719
2022 Q2	$1K	Sell	10 -4	-29%	-$379	﹤0.01%	1215
2022 Q1	$1K	Buy	+14	New	+$1.36K	﹤0.01%	1301

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Disciplined Investments's HZNP Position: Q3 2023 in Review

Disciplined Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 18 shares — an estimated $1.85K sold.

Disciplined Investments first reported a position in HZNP in Q1 2022 and held it in 6 quarters. The position peaked at $2.05K in Q4 2022. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

Disciplined Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Disciplined Investments sold 18 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $1.85K.
Disciplined Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2022 and held it in 6 quarters.
Disciplined Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.05K in Q4 2022.
485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.